Surgery Partners Debt-to-Equity Ratio Growth & History (SGRY)
Surgery Partners's debt-to-equity ratio was 2.35 for fiscal 2025.
View full Surgery Partners company overviewSurgery Partners annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.35 | 0.28 | +13.55% |
| 2024 | 2024-12-31 | 2.07 | 0.53 | +34.31% |
| 2023 | 2023-12-31 | 1.54 | 0.07 | +5.08% |
| 2022 | 2022-12-31 | 1.47 | −1.56 | −51.54% |
| 2021 | 2021-12-31 | 3.03 | −24.63 | −89.06% |
| 2020 | 2020-12-31 | 27.65 | 17.88 | +182.93% |
| 2019 | 2019-12-31 | 9.77 | 4.02 | +69.99% |
| 2018 | 2018-12-31 | 5.75 | 2.40 | +71.47% |
| 2017 | 2017-12-31 | 3.35 | −145.68 | −97.75% |
| 2016 | 2016-12-31 | 149.04 | — | — |
Surgery Partners quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.43 | 0.21 | +9.49% |
| Q1 2026 | 2026-03-31 | 2.39 | 0.17 | +7.50% |
| Q4 2025 | 2025-12-31 | 2.35 | 0.28 | +13.55% |
| Q3 2025 | 2025-09-30 | 2.24 | 0.38 | +20.62% |
| Q2 2025 | 2025-06-30 | 2.22 | 0.46 | +26.31% |
| Q1 2025 | 2025-03-31 | 2.22 | 0.61 | +38.23% |
| Q4 2024 | 2024-12-31 | 2.07 | 0.53 | +34.31% |
| Q3 2024 | 2024-09-30 | 1.86 | 0.37 | +24.87% |
| Q2 2024 | 2024-06-30 | 1.76 | 0.33 | +23.47% |
| Q1 2024 | 2024-03-31 | 1.61 | 0.13 | +8.63% |
| Q4 2023 | 2023-12-31 | 1.54 | 0.07 | +5.08% |
| Q3 2023 | 2023-09-30 | 1.49 | −1.52 | −50.57% |
| Q2 2023 | 2023-06-30 | 1.42 | −1.52 | −51.61% |
| Q1 2023 | 2023-03-31 | 1.48 | −1.45 | −49.53% |
| Q4 2022 | 2022-12-31 | 1.47 | −1.56 | −51.54% |
| Q3 2022 | 2022-09-30 | 3.01 | −1.23 | −29.07% |
| Q2 2022 | 2022-06-30 | 2.94 | −1.25 | −29.85% |
| Q1 2022 | 2022-03-31 | 2.93 | −6.54 | −69.06% |
| Q4 2021 | 2021-12-31 | 3.03 | −24.63 | −89.06% |
| Q3 2021 | 2021-09-30 | 4.24 | −27.05 | −86.46% |
| Q2 2021 | 2021-06-30 | 4.19 | −10.60 | −71.67% |
| Q1 2021 | 2021-03-31 | 9.47 | −3.22 | −25.37% |
| Q4 2020 | 2020-12-31 | 27.65 | 17.88 | +182.93% |
| Q3 2020 | 2020-09-30 | 31.29 | 22.86 | +271.13% |
| Q2 2020 | 2020-06-30 | 14.79 | 7.14 | +93.27% |
| Q1 2020 | 2020-03-31 | 12.69 | 5.70 | +81.61% |
| Q4 2019 | 2019-12-31 | 9.77 | 4.02 | +69.99% |
| Q3 2019 | 2019-09-30 | 8.43 | 4.62 | +121.48% |
| Q2 2019 | 2019-06-30 | 7.65 | 4.01 | +110.27% |
| Q1 2019 | 2019-03-31 | 6.99 | 3.52 | +101.78% |
| Q4 2018 | 2018-12-31 | 5.75 | 2.40 | +71.47% |
| Q3 2018 | 2018-09-30 | 3.81 | 0.65 | +20.70% |
| Q2 2018 | 2018-06-30 | 3.64 | −288.30 | −98.75% |
| Q1 2018 | 2018-03-31 | 3.46 | −170.23 | −98.01% |
| Q4 2017 | 2017-12-31 | 3.35 | −145.68 | −97.75% |
| Q3 2017 | 2017-09-30 | 3.15 | — | — |
| Q2 2017 | 2017-06-30 | 291.94 | — | — |
| Q1 2017 | 2017-03-31 | 173.69 | — | — |
| Q4 2016 | 2016-12-31 | 149.04 | — | — |
Surgery Partners debt-to-equity ratio trends
Over the last five fiscal years, Surgery Partners's debt-to-equity ratio decreased from 27.65 to 2.35, a change of −25.31. The latest reported quarter, Q2 2026, shows 2.43.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Surgery Partners source filings ↗